Narcolepsy clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for

  • ALKS 2680 in Subjects With Narcolepsy Type 2

    open to eligible people ages 18-70

    The purpose of this study is to measure the safety and decrease in sleepiness in subjects with narcolepsy type 2 (NT2) when taking ALKS 2680 tablets compared to placebo tablets.

    at UCSF

  • Child and Adolescent Registry for Participants With Narcolepsy

    open to eligible people ages up to 17 years

    CATNAP is a patient registry designed to improve the understanding of the natural history of narcolepsy in pediatric patients. Descriptive statistics on disease characteristics will be performed. The study has 16 active clinical sites and a virtual site that widens participation to anywhere in the United States. For more information about the study or to access the Online Patient Enrollment System, visit the CATNAP website: https://catnap.healthie.net/welcome or email catnap@pulseinfoframe.com. The Online Patient Enrollment System, CATNAP website, can also be found in the references section.

    at UCSD

Last updated: